BACKGROUND: Many studies have indicated that medical therapy and percutaneous coronary intervention have similar effects in terms of the long-term prognosis of patients with stable coronary artery disease. This study investigated the effects of optimal medical therapy (OMT) and revascularization-plus-OMT in elderly patients with high-risk angina. METHODS: In this prospective non-randomized study, 241 consecutive high-risk elderly male patients (65-92 years of age) with angiographically confirmed multivessel disease were enrolled in the registry from January 2004 to April 2005. Of these, 98 patients underwent OMT and 143 underwent revascularization therapy plus OMT. RESULTS: After 6.5 years of follow-up, we found that the rate of long-term cardiac mortality was significantly higher in patients who underwent OMT than in those who underwent revascularization (6.5-year unadjusted mortality rate, 14.3% for OMT vs. 7.0% for revascularization patients; log-rank P = 0.04). However, the overall risks of major adverse cardiac cerebrovascular events (MACCE) were similar among all patients (6.5-year unadjusted mortality rate, 29.6% for OMT vs. 27.3% for revascularization patients; log-rank P = 0.67). CONCLUSIONS: OMT was associated with an increase in cardiac death but a similar 6.5-year risk of MACCE compared with revascularization in high-risk elderly male patients with coronary multivessel disease.
BACKGROUND: Many studies have indicated that medical therapy and percutaneous coronary intervention have similar effects in terms of the long-term prognosis of patients with stable coronary artery disease. This study investigated the effects of optimal medical therapy (OMT) and revascularization-plus-OMT in elderly patients with high-risk angina. METHODS: In this prospective non-randomized study, 241 consecutive high-risk elderly male patients (65-92 years of age) with angiographically confirmed multivessel disease were enrolled in the registry from January 2004 to April 2005. Of these, 98 patients underwent OMT and 143 underwent revascularization therapy plus OMT. RESULTS: After 6.5 years of follow-up, we found that the rate of long-term cardiac mortality was significantly higher in patients who underwent OMT than in those who underwent revascularization (6.5-year unadjusted mortality rate, 14.3% for OMT vs. 7.0% for revascularization patients; log-rank P = 0.04). However, the overall risks of major adverse cardiac cerebrovascular events (MACCE) were similar among all patients (6.5-year unadjusted mortality rate, 29.6% for OMT vs. 27.3% for revascularization patients; log-rank P = 0.67). CONCLUSIONS:OMT was associated with an increase in cardiac death but a similar 6.5-year risk of MACCE compared with revascularization in high-risk elderly male patients with coronary multivessel disease.
Entities:
Keywords:
Coronary multivessel disease; High risk; Optimal medical therapy; Revascularization; The elderly
Authors: Theodore D Fraker; Stephan D Fihn; Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T Bruce Ferguson; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy Journal: J Am Coll Cardiol Date: 2007-12-04 Impact factor: 24.094
Authors: Harlan M Krumholz; Jeffrey L Anderson; Brian L Bachelder; Francis M Fesmire; Stephan D Fihn; Joanne M Foody; P Michael Ho; Mikhail N Kosiborod; Frederick A Masoudi; Brahmajee K Nallamothu Journal: Circulation Date: 2008-11-10 Impact factor: 29.690
Authors: K B Allen; R D Dowling; T L Fudge; G P Schoettle; S L Selinger; D M Gangahar; W W Angell; M R Petracek; C J Shaar; W W O'Neill Journal: N Engl J Med Date: 1999-09-30 Impact factor: 91.245
Authors: Matthias Pfisterer; Peter Buser; Stefan Osswald; Urs Allemann; Wolfgang Amann; Walter Angehrn; Eric Eeckhout; Paul Erne; Werner Estlinbaum; Gabriela Kuster; Tiziano Moccetti; Barbara Naegeli; Peter Rickenbacher Journal: JAMA Date: 2003-03-05 Impact factor: 56.272
Authors: Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith Journal: J Am Coll Cardiol Date: 2002-10-02 Impact factor: 24.094
Authors: Raymond J Gibbons; Jonathan Abrams; Kanu Chatterjee; Jennifer Daley; Prakash C Deedwania; John S Douglas; T Bruce Ferguson; Stephan D Fihn; Theodore D Fraker; Julius M Gardin; Robert A O'Rourke; Richard C Pasternak; Sankey V Williams Journal: J Am Coll Cardiol Date: 2003-01-01 Impact factor: 24.094
Authors: David J Maron; John A Spertus; G B John Mancini; Pamela M Hartigan; Steven P Sedlis; Eric R Bates; William J Kostuk; Marcin Dada; Daniel S Berman; Leslee J Shaw; Bernard R Chaitman; Koon K Teo; Robert A O'Rourke; William S Weintraub; William E Boden Journal: Am J Cardiol Date: 2009-08-28 Impact factor: 2.778
Authors: Madeleine Eickhoff; Stefanie Schüpke; Alexander Khandoga; Julia Fabian; Moritz Baquet; David Jochheim; David Grundmann; Manuela Thienel; Axel Bauer; Hans Theiss; Stefan Brunner; Jörg Hausleiter; Steffen Massberg; Julinda Mehilli Journal: J Geriatr Cardiol Date: 2018-09-28 Impact factor: 3.327